| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vesicle transport through interaction with t-SNAREs 1B pseudogene 3 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
MAPT antisense RNA 1 | 0.711 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
SEMA3F antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
ZSCAN16 antisense RNA 1 | 0.792 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
MAPRE3 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||||
|
CCNT2 antisense RNA 1 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
urate (hydroxyiso-) hydrolase, pseudogene | 1.000 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||||
|
USP3 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
CCDC18 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
CADM3 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1004 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
LMCD1 antisense RNA 1 | 0.780 | 0.346 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2018 | 2018 | |||||||||
|
OTX2 antisense RNA 1 (head to head) | 0.931 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
FCF1 pseudogene 7 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
BAALC antisense RNA 1 | 0.760 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1539 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
mitosis associated long intergenic non-coding RNA 1 | 0.890 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
TMEM161B antisense RNA 1 | 0.931 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
SIX3 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
MIR3681 host gene | 0.736 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
C5orf64 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
DPH6 divergent transcript | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2018 | 2018 | |||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
UBE2F-SCLY readthrough (NMD candidate) | 1.000 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||||||
|
ZRANB2 antisense RNA 2 (head to head) |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 |